Published

Study finds encouraging results in psilocybin treatment for TRD patients

Results of new psychedelic research aimed at patients with severe treatment resistant depression (TRD) found significant decreases in their depressive symptoms. Researchers of the open-label study also found significant safety and efficacy of synthetic psilocybin in TRD patients.

Open source BibTeX RIS

Bibliographic context

Journal: Mental Health Weekly
Date: 2025-01-09
Source: OpenAlex
DOI: 10.1002/mhw.34292
PubMed: Unavailable

Authors

Valerie A. Canady

Watch author

Topics and keywords

psilocybin Depression Pharmacology Aging Treatment-Resistant Depression Safety Other Psilocybin Psychology Medicine Hallucinogen Pharmacology Psychedelics and Drug Studies Mental Health and Psychiatry Sexuality Behavior and Technology

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Study finds encouraging results in psilocybin treatment for TRD patients2025-01-09

Related papers

Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31 Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27 Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer PatientsDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11